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Abstract
We examined whether colonization of selected oral pathogens is associated with gastric precancerous lesions in a cross-
sectional study. A total of 119 participants were included, of which 37 were cases of chronic atrophic gastritis, intestinal
metaplasia, or dysplasia. An oral examination was performed to measure periodontal indices. Plaque and saliva samples
were tested with real-time quantitative PCR for DNA levels of pathogens related to periodontal disease (Porphyromonas
gingivalis, Tannerella forsythensis, Treponema denticola, Actinobacillus actinomycetemcomitans) and dental caries
(Streptococcus mutans and S. sobrinus). There were no consistent associations between DNA levels of selected bacterial
species and gastric precancerous lesions, although an elevated but non-significant odds ratio (OR) for gastric precancerous
lesions was observed in relation to increasing colonization of A. actinomycetemcomitans (OR = 1.36 for one standard
deviation increase, 95% Confidence Interval = 0.87–2.12), P. gingivalis (OR = 1.12, 0.67–1.88) and T. denticola (OR = 1.34, 0.83–
2.12) measured in plaque. To assess the influence of specific long-term infection, stratified analyses by levels of periodontal
indices were conducted. A. actinomycetemcomitans was significantly associated with gastric precancerous lesions (OR= 2.51,
1.13–5.56) among those with $ median of percent tooth sites with PD$3 mm, compared with no association among those
below the median (OR= 0.86, 0.43–1.72). A significantly stronger relationship was observed between the cumulative
bacterial burden score of periodontal disease-related pathogens and gastric precancerous lesions among those with higher
versus lower levels of periodontal disease indices (p-values for interactions: 0.03–0.06). Among individuals with periodontal
disease, high levels of colonization of periodontal pathogens are associated with an increased risk of gastric precancerous
lesions.
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Background
Gastric cancer is the fourth most common cancer and second
highest in mortality worldwide [1]. In 2008, there were
approximately 989,000 new gastric cancers diagnosed globally
and 738,000 deaths. While environmental and lifestyle factors
including H. pylori colonization, cigarette smoking, dietary intake
of salt and preserved foods, and low intake of Vitamin C and
vegetables, all contribute to the etiology of the malignancy [2–4],
these risk factors could only explain less than 60% of gastric cancer
incidence [5].
For the most common ‘‘intestinal’’ subtype of gastric adeno-
carcinomas, which account for approximately 70% of gastric
cancer cases [2], [6], a pre-neoplastic sequence has been defined
from chronic superficial gastritis through atrophic gastritis,
intestinal metaplasia, and ultimately to dysplasia and adenocarci-
noma [7], [8]. Studies of gastric precancerous lesions can be used
to identify risk factors that play a role in the development of gastric
cancer. Several case-control studies of gastric precancerous lesions,
predominantly atrophic gastritis and intestinal metaplasia, have
identified common risk factors for gastric cancer such as cigarette
smoking, old age, and low levels of fruit or vitamin C intake [9–
14].
The association of self-reported tooth loss or poor oral hygiene
with increased risk of gastric cancer has been reported in several
epidemiologic studies with diverse populations [15–19]. We have
previously reported a significant positive association between
active gingival bleeding and presence of gastric precancerous
lesions in a cross-sectional study of an endoscopic population [20],
consistent with the hypothesis that periodontal disease may
increase the risk of gastric cancer. However, these studies lack
information on specific oral pathogens necessary to elucidate the
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role of oral health in gastric cancer development. The investiga-
tion of specific oral pathogens related to gastric cancer or gastric
precancerous lesions may help identify the underlying mechanisms
and generate knowledge that may lead to improved clinical
treatment and interventions. In this study, we examined the
association between selected oral pathogens and presence of
gastric precancerous lesions. We considered microbes that are
etiologically linked with periodontal diseases [21], including
Porphyromonas gingivalis, a gram-negative oral anaerobe commonly
associated with adult periodontal disease [22]; Tannerella forsythensis,
an anaerobic gram-negative member of the Cytophaga-Bacteroi-
des family implicated in periodontal diseases, Treponema denticola, a
motile and highly proteolytic bacterium associated with the
incidence and severity of human periodontal disease, and
Actinobacillus actinomycetemcomitans, a gram-negative facultative
anaerobe, which is not only a typical cause of periodontitis but
also associated with systemic infections [23], [24]. We also
measured levels of Streptococcus mutans and S. sobrinus, gram-positive




A detailed description of the study has been presented elsewhere
[20]. Briefly, subjects $40 years of age undergoing an upper
endoscopy at Bellevue Hospital Center in New York City were
invited to participate in the study. Information about demographic
and lifestyle factors was collected using structured questionnaires
administered by a trained interviewer.
Serum samples were collected at the time of endoscopy and
were tested for H. pylori using ELISA for IgG antibodies to H. pylori
whole cell antigens in duplicate and in parallel with known positive
controls (cutoff for positivity was an optical density ratio .1.0
[27]). IgG antibodies to cagA were measured by ELISA (the cutoff
for positivity was an optical density ratio .0.35 [28]).
Endoscopic evaluation was performed using Olympus GIF-
XQ140 or GIFQ-160 videoendoscopes following existing protocol
[29]. A total of 8 biopsies of approximately 26262 mm in
dimensions were obtained from the stomach (4 from the antrum,
and 2 each from the corpus and fundus) and 2 from the distal
esophagus 2 cm above the gastroesophogeal junction. Biopsy
specimens were processed according to pre-established standard-
ized protocols and reviewed by an experienced gastrointestinal
histopathologist (Z.P.) designated to the study [20]. The pathol-
ogist reviewed all biopsy specimens and was blinded to question-
naire data and findings from the oral examination [20].
Parameters evaluated for gastric biopsies in cluded (a) degree of
acute inflammation (b) atrophy, and (c) intestinal metaplasia. The
degree of gastritis was scored using the updated Sydney System
[30]. Participants were categorized according to the most
advanced lesion found. Results from biopsies were classified as
cases and non-cases: 1) cases had chronic atrophic gastritis,
intestinal metaplasia, or dysplasia; and 2) non-cases had either
chronic superficial gastritis or no evidence of gastric lesions.
The Institutional Review Boards of New York University
School of Medicine and Bellevue Hospital Center approved all
procedures involving human subjects. Written informed consent
was obtained from all subjects at time of enrollment.
Overall, 283 eligible participants were approached, and 162
were recruited between April 2009 and April 2011. One hundred
thirty one (131) subjects underwent an oral health clinical
assessment and provided saliva and plaque samples for microbi-
ological evaluation. Participants and non-participants were rela-
tively similar in demographic distribution; roughly two thirds of
non-participants were of Asian or Hispanic race/ethnicity, 60%
were female, and their average age was 58 years. The top three
reasons for declining participation (80%) included: not having time
for the oral exam, not interested in the present research, and not
wanting to participate in research studies in general. As of April
2012, complete data on selected oral pathogens was available from
119 participants (37 cases and 82 non-cases).
Oral examination and collection of saliva and plaque
sample
Details of the oral examination have been previously presented
elsewhere [20]. Within 1–4 weeks following upper endoscopy, a
dental hygienist calibrated in all assessments performed a
comprehensive oral examination on all participants, and was
blinded to biopsy results of gastroenterology. Periodontal assess-
ments were standardized in a calibration session performed prior
to the study and followed National Institute of Dental and
Craniofacial Research diagnostic criteria, used previously in the
Oral Health Survey of U.S. Adults [31]. Periodontal examinations
involved assessments at six tooth sites (mesiobuccal, buccal,
distobuccal, distolingual, lingual and mesiolingual) of all teeth
present, using a manual North Carolina 15 periodontal probe
[32]. Levels of clinical attachment loss (CAL), defined as the
distance from the cemento-enamel junction to the free gingival
margin in millimeters, and periodontal probing depth (PD),
defined as the distance from the free gingival margin to the bottom
of the pocket to the nearest whole millimeter, were recorded for
each of the six tooth surfaces assessed. Bleeding on probing (BOP)
was recorded dichotomously for each tooth surface and deemed
positive if it occurred within 15 seconds after the assessment of
probing depth.
All subjects were asked to chew a piece of paraffin wax and then
to gently expectorate 2–5 ml of saliva directly into a sample
collection tube, on ice. A total of 6 plaque samples were collected
from each subject with sterile curettes; 4 supragingival plaque
samples from the 1st molar or most posterior tooth in each
quadrant and 2 subgingival plaque samples from teeth exhibiting
the deepest periodontal pockets. The plaque samples were
immediately transferred to a pre-labeled sterile sample vial
containing 200 ml TE buffer. Both saliva and plaques samples
were vortex-mixed thoroughly for 30 sec, immediately placed into
a container containing ice, and transferred to the laboratory within
1 h for further processing.
Quantitative real-time PCR assays
Quantitative real-time PCR was performed to detect the
presence/absence and to quantify targeted bacterial DNA in the
saliva and plaque samples. Bacterial genomic DNA was isolated
using the MasterPure DNA purification kit (Epicentre, Madison,
WI) following previously established procedures [33]. After DNA
isolation, the total genomic DNA concentration of each sample
was quantified using a UV spectrophotometer at 260 nm and
280 nm (NanoDrop 2000C, Thermo Scientific, Wilmington, DE).
The final concentration of each DNA sample was adjusted to
10 ng/ml for real-time qPCR. The qPCR reaction mixture
contained a total volume of 25 ml, which consisted of 106buffer,
2.5 mM/ea dNTPs, 10 pmole/ml primers, 5 U/ml Taq, 50 mm
MgCl2, and 20 ng/ml DNA template. The amplifying reaction of
DNA in a volume of 25 ml was composed of 16 QuantiTect
SYBR Green PCR Master Mix (Qiagen), 10,100 ng of total
genomic DNA and 0.4 mM of each primer. The species-specific
PCR primers used in this study are listed in Table S1. All PCR
programs used for the amplifying reactions are listed in Table S2.
Oral Pathogens and Gastric Precancerous Lesions
PLOS ONE | www.plosone.org 2 January 2013 | Volume 8 | Issue 1 | e51604
Serial dilutions (10-fold) of standard DNA concentrations of P.
gingivalis (ATCC33277), T. forsythensis (ATCC43037), T. denticola
(ATCC35404), A. actinomycetemcomitans (ATCC29522), S. mutans
(UA159), and S. sobrinus (OMZ176), were used in each reaction as
external standards for absolute quantification of the targeted
bacteria. DNA levels for all 6 bacterial species were measured in
saliva samples, and 4 bacterial species relevant to periodontal
disease (A. actinomycetemcomitans, P. gingivalis, T. denticola, T. forsythia)
were measured in each plaque sample. We tested for the
colonization of S. sobrinus and S. mutans in saliva rather than in
plaque because the plaque samples were collected from specific
tooth sites exhibiting the deepest periodontal pockets and may not
truly reflect the overall prevalence of these cariogenic microor-
ganisms in the oral cavity. Use of our real-time PCR method
involving stimulated whole saliva has been a standard and well-
documented procedure for evaluating prevalence of S. sobrinus and
S. mutans [34], [35]. The analytical specificity of the fluorescence
signal was determined on the basis of subsequent melting curve
analysis. All reactions were carried out in duplicate, and the final
analyses were based on the mean of the two reactions. Output data
were analyzed using Opticon Monitor 2 software (MJ Research).
Statistical Analyses
We first conducted descriptive analyses comparing participants
with gastric precancerous lesions and those without gastric
precancerous lesions in terms of socio-demographic, lifestyle
characteristics, and periodontal disease indices, including CAL,
BOP, and PD. We estimated Odds Ratios (ORs) for gastric
precancerous lesions in relation to bacterial DNA levels in saliva
samples and plaque samples by entering each measure as a
continuous variable in serially adjusted models. DNA levels for
each bacterial species measured in plaque were averaged for each
individual (6 samples per person). Log-transformations of bacterial
DNA levels were considered to postulate that disease risk is
proportional to a power of dose in bacterial DNA levels (a log-
linear relation between log odds and exposure), a relationship
known to occur frequently from both human and animal studies
[36]. To facilitate interpretation, we estimated ORs for gastric
precancerous lesions in relation to a one standard deviation (SD)
increase in log-transformed bacterial DNA levels of each of the
bacterial species.
We also created a cumulative summary score of bacterial
burden for bacterial species etiologically related to periodontal
disease (A. actinomycetemcomitans, P. gingivalis, T. denticola, T. forsythia
[21], [37]) and dental caries (S. mutans and S. sobrinus [25], [38]).
The average colonization level of each species was natural log-
transformed and standardized by dividing each person-specific
value by the log-transformed population standard deviation (SD).
One SD on the natural log scale was hence equivalent across
microbes. The standardized values were then summed and
grouped accordingly. We estimated ORs for gastric precancerous
lesions in relation to the cumulative summary score entered as a
continuous variable. ORs were adjusted for major risk factors of
gastric cancer that may be related to oral health, and these factors
included age, sex, ethnic background, smoking status, body mass
index, H. pylori status, and educational attainment.
Since clinical periodontal disease is a manifestation of long-term
infection of periodontal pathogens, we conducted stratified
analyses to assess whether the association between periodontal
disease-related pathogens and gastric precancerous lesions differs
by periodontal indices, including CAL, BOP, and PD. The
median values for percentage of tooth sites with BOP, CAL
$3 mm, and PD$3 mm were considered cut-points in stratified
analyses. Significance of the interaction was tested using a cross-
product term between a given periodontal disease index and a
given periodontal disease bacterial species (or the cumulative
burden of all four species), all entered as continuous variables in
the model. Sensitivity analyses were performed using different cut-
points for periodontal indices (e.g., percentage of sites with
CAL$5 mm and PD$4 mm). Exploratory analyses were con-
ducted to assess whether the exposure-disease association differed
by H. pylori status.
We performed all statistical analyses using SAS 9.2 (SAS
Institute, Inc., Cary, North Carolina). All tests were two sided and
P,0.05 was considered significant.
Results
Participants were largely of Hispanic ethnicity (45.4%), female
(63.0%) and had a mean age of 57 years. Cases had a significantly
higher prevalence of smoking (p= 0.02) and were more likely to
have tested positive for H. pylori colonization (particularly with cagA
strain, p = 0.07) than non-cases (Table 1). When we compared
mean levels of periodontal indices by case group, we found a
higher mean percentage of gingival bleeding sites (p = 0.04) among
cases than non-cases. There were no other significant differences
in periodontal disease indices by case status. As expected, we
observed that the means of log-transformed periodontal pathogen
DNA levels in plaque increased across tertiles of periodontal
indices (Table S3). The DNA levels of periodontal pathogens
were generally higher among those who did not floss as compared
to those who did floss, although most did not reach statistical
significance (data not shown).
Age and gender adjusted mean bacterial DNA levels in either
saliva or plaque samples were not significantly different by case
status (Table 2). Results from multivariate logistic regression
models using log-transformed bacterial DNA levels appear
generally similar. In saliva, there was no evidence that levels of
caries-related bacteria were related to gastric precancerous lesions.
For periodontal disease-related bacteria, DNA levels for T. forsythia
were significantly inversely associated with gastric precancerous
lesions in a model adjusted by age and gender (OR=0.59, 0.40–
0.88) and in the fully adjusted model (OR=0.61, 0.38–0.98).
There was no evidence that levels of other periodontal disease-
related bacteria in saliva were related to gastric precancerous
lesions. In plaque, however, there was no evidence of an
association between DNA levels for T. forsythia. A. actinomycetemco-
mitans and T. denticola in plaque samples were positively associated
with gastric precancerous lesions (ORs for one SD increase in log-
transformed bacterial levels: 1.36, p = 0.17 and 1.34, p = 0.23,
respectively; model 2). However, these associations did not reach
statistical significance. Using the summary measure of bacterial
burden in plaque, we similarly found a positive albeit non-
significant association between one SD increase in log-transformed
bacterial burden level and presence of gastric precancerous lesions
in a fully adjusted multivariable model (OR=1.22, 95%
confidence interval: 0.77–1.92). Sensitivity analyses were per-
formed using different cut-points for periodontal indices (e.g.,
percentage of sites with CAL$5 mm and PD$4 mm). However,
the results were similar and are not shown here.
To assess the effect of more specific long-term infection, we
further investigated whether the association between periodontal
pathogens in plaque and gastric precancerous lesions differed by
periodontal disease indices (Table 3). The odds ratio for gastric
precancerous lesions associated with one SD increase in levels of A.
actinomycetemcomitans was greater (OR: 2.51, 95% CI= 1.13–5.56)
among participants with a higher percentage of tooth sites ($ the
median) with PD$3 mm, after controlling for gender, age, race,
Oral Pathogens and Gastric Precancerous Lesions
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smoking status, educational attainment, BMI, and H. pylori status.
By contrast, this effect was considerably attenuated among those
with a lower percentage of sites (, the median) with PD$3 mm
(OR=0.86, 95% CI= 0.43–1.72). The association between A.
actinomycetemcomitans and gastric precancerous lesions was also
elevated among individuals with a higher percentage of sites with
CAL$3 mm (OR=1.92, 95% CI= 0.96–3.85) and a higher
percentage of BOP (OR=1.38, 95% CI= 0.72–2.65). Similar
patterns of associations were evident for other periodontal disease-
related pathogens. When the cumulative summary score of all four
bacterial species was used in the analyses, we observed that the
association between one SD increase in the summary score and
gastric precancerous lesions among participants with higher levels
of periodontal disease (i.e., percentage of sites with BOP,
PD$3 mm, or CAL$3 mm) was significantly or marginally
significantly stronger than those with lower levels of periodontal
disease (p-values for interaction ranged from 0.03–0.06). Lastly, in
exploratory analyses, we investigated whether the associations
between oral pathogens and gastric precancerous lesions differed
by H. pylori. The associations were not appreciably different by H.
pylori status and the results are therefore not shown.
Discussion
Previous studies have reported positive associations between
poor oral health and tooth loss with gastric cancer [15–18]. Ours is
the first to investigate associations between DNA levels of oral
pathogens and presence of gastric precancerous lesions. In the
present study, there was no consistent association between DNA
levels of selected bacterial species etiologically related to
periodontal disease and presence of gastric precancerous lesions.
Among those with higher levels of periodontal disease, periodontal
pathogens measured in plaque were positively related to presence
of gastric precancerous lesions, independent of gender, age, race,
smoking status, educational attainment, BMI, and H. pylori status.
The findings support the role of specific manifestations of
periodontal disease and periodontal infection in the development
of gastric cancer.
It has been proposed that bacterial infections are linked with
gastric cancer through the induction of systemic or gastric chronic
inflammation [39]. In the classic example of H. pylori, infection
with one pathogen alone triggers chronic inflammation and leads
to gastric non-cardia adenocarcinoma [40–42]. Periodontal
pathogen A. actinomycetemcomitans has been associated with
increased secretion of interleukins 1a and 1b and tumor necrosis
factor a, cytokines that are involved in the inflammatory response
[43], [44]. High serum titre to P. gingivalis and the presence of
periodontal disease are independently related to high C-reactive
protein levels [45]. Recently, polymorphisms in the gene of
Interleukin 6, a pro-inflammatory cytokine, were associated with
A. actinomycetemcomitans, P. gingivalis, T. denticola, and T. forsythia [46].
Periodontal disease is a set of inflammatory conditions that leads to
destruction of the supporting alveolar bone, connective tissue, and
eventual tooth loss [47]. In this study, DNA levels for T. forsythia in
saliva were significantly inversely associated with gastric precan-
Table 1. Distributions of participant characteristics by status
of gastric precancerous lesions, n = 119.
Patient





Men 32.4 39.0 0.49
Women 67.6 61.0
Age, years
Mean (SD) 58.2 (9.0) 56.9 (9.0) 0.442
Education, %
Less than high school 40.5 34.2 0.71











Mean (SD) 26.8 (7.3) 26.2 (6.2) 0.692
Smoking Status, %








Yes 73.0 74.7 0.87
Coffee
Consumption, %
Yes 73.0 69.1 0.67
Place of Birth, %
Foreign born 94.6 87.8 0.343
H.pylori status (in
serum), %
Negative 31.4 53.3 0.07
Positive
cagA negative 14.3 13.3
cagA positive 54.3 33.3
% Bleeding sites
Mean (SD) 30.0 (21.3) 21.4 (17.0) 0.042
% sites with
PD$3 mm
Mean (SD) 21.9 (18.9) 20.8 (17.5) 0.762
Mean PD (SD), mm 2.0 (0.6) 1.9 (0.5) 0.652
% sites with
CAL$3 mm
Mean (SD) 32.2 (22.0) 32.8 (21.2) 0.892
Mean CAL (SD), mm 2.4 (0.9) 2.4 (0.7) 0.902
PD=Pocket Depth, CAL= Clinical Attachment Loss.
1p-value by chi-square test.
2p-value for t-test.
3p-value by two-sided fisher exact test.
doi:10.1371/journal.pone.0051604.t001
Table 1. Cont.
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Table 2. Adjusted means and odds ratios for gastric precancerous lesions in relation to bacterial DNA levels, n = 119.
Bacterial DNA levels Adjusted means
1 (SE) ORs2 for gastric precancerous lesions (95% CI)
Cases N=37 Non-cases N=82 P-value Model 1 Model 2
Saliva
A. actinomycetemcomitans (Aa) 2.0 (0.9) 0.9 (0.6) 0.30 1.14 (0.78–1.67) 1.12 (0.73–1.74)
P. gingivalis3 (Pg) 2.1 (1.1) 2.6 (0.7) 0.66 0.98 (0.66–1.45) 1.06 (0.61–1.83)
T. denticola (Td) 4.3 (8.9) 15.4 (5.9) 0.29 0.95 (0.64–1.41) 1.10 (0.67–1.79)
T. forsythia4 (Tf) 2.1 (7.0) 6.7 (4.7) 0.58 0.59 (0.40–0.88) 0.61 (0.38–0.98)
S. sobrinus (Sb) 3.1 (2.0) 0.5 (1.3) 0.28 1.09 (0.73–1.61) 0.98 (0.78–1.24)
S. mutans (Sm) 4.3 (2.8) 8.0 (1.9) 0.27 0.89 (0.60–1.33) 0.98 (0.84–1.15)
Cumulative burden5 (Sb, Sm) 21.8 (0.3) 21.8 (0.2) 0.92 0.98 (0.65–1.47) 0.94 (0.60–1.49)
Cumulative burden5 (Aa, Pg, Td, Tf) 21.2 (0.5) 20.7 (0.3) 0.43 0.85 (0.57–1.27) 0.91 (0.56–1.49)
Plaque
A. actinomycetemcomitans (Aa) 1.6 (1.5) 1.5 (1.0) 0.96 1.28 (0.87–1.89) 1.36 (0.87–2.12)
P. gingivalis3 (Pg) 6.2 (3.8) 9.6 (2.5) 0.45 0.99 (0.67–1.47) 1.12 (0.67–1.88)
T. denticola4 (Td) 1.3 (0.9) 1.5 (0.6) 0.90 1.15 (0.77–1.71) 1.34 (0.83–2.15)
T. forsythia6 (Tf) 3.9 (1.7) 5.0 (1.1) 0.59 0.76 (0.52–1.11) 0.90 (0.58–1.38)
Cumulative burden5 (Aa, Pg, Td, Tf) 0.6 (0.5) 0.5 (0.3) 0.88 1.03 (0.69–1.54) 1.22 (0.77–1.92)
1Means of absolute bacterial counts (ng/ml) adjusted for age and sex.
2ORs estimated in relation to a standard deviation increase in the log-transformed bacterial DNA levels. Model 1 was adjusted for age and sex. Model 2 was further
adjusted for race, smoking status, educational attainment, BMI, and H. pylori status.
3Bacterial counts in 16102 ng/ml.
4Bacterial counts in 16104 ng/ml.
5Cumulative burden is the sum of the log-transformed and standardized values of bacterial counts.
6Bacterial counts in 16103 ng/ml.
doi:10.1371/journal.pone.0051604.t002
Table 3. Adjusted odds ratios for gastric precancerous lesions in relation to selected periodontal pathogen DNA levels and
stratified by periodontal disease severity1.
Odds ratios2 for gastric precancerous lesions (95% CI)




$18.8 22/37 1.38 (0.72–2.65) 1.19 (0.60–2.37) 1.30 (0.67–2.52) 1.43 (0.72–2.84) 1.42 (0.75–2.70)
,18.8 15/45 0.42 (0.11–1.61) 0.63 (0.23–1.76) 1.12 (0.46–2.75) 0.27 (0.09–0.83) 0.39 (0.13–1.13)
P for interaction4 0.30 0.31 0.39 0.06 0.06
% PD$3 mm
$16.7 17/40 2.51 (1.13–5.56) 1.66 (0.75–3.64) 1.61 (0.79–3.30) 1.36 (0.69–2.66) 2.00 (0.97–4.13)
,16.7 20/42 0.86 (0.43–1.72) 0.88 (0.43–1.87) 1.12 (0.55–2.31) 0.54 (0.26–1.13) 0.73 (0.35–1.51)
P for interaction4 0.08 0.18 0.16 0.07 0.04
% CAL $3 mm
$29.2 18/39 1.92 (0.96–3.85) 1.47 (0.61–3.56) 1.23 (0.58–2.62) 1.08 (0.57–2.07) 1.54 (0.75–3.19)
,29.2 19/43 0.97 (0.43–2.18) 1.04 (0.45–2.36) 1.72 (0.74–3.98) 0.68 (0.31–1.51) 1.03 (0.46–2.32)
P for interaction4 0.14 0.03 0.27 0.04 0.03
PD= Pocket Depth, CAL =Clinical Attachment Loss.
1Cut-points for periodontal disease severity were determined at the median.
2ORs estimated in relation to a standard deviation increase in the log-transformed bacterial DNA levels and adjusted for gender, age, race, smoking status, educational
attainment, BMI, and H. pylori status.
3Cumulative bacterial burden is a summary measure estimated by standardizing each bacterial DNA level (dividing each person-specific value by the log-transformed
population standard deviation) and summing these values across all four species.
4P-value for the cross-product term of each log-transformed bacterial DNA level and each periodontal index entered as continuous variables.
doi:10.1371/journal.pone.0051604.t003
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cerous lesions. However, there was no evidence for this in plaque.
A non-significant positive association was observed between other
periodontal disease-related bacteria measured in plaque and
gastric precancerous lesions. Among individuals with more severe
symptoms of periodontal disease, we observed consistent and
positive associations between periodontal pathogens and gastric
precancerous lesions. It is possible that higher levels of periodontal
pathogens in individuals with a higher percentage of BOP and
deeper periodontal pockets are indicative of more specific long-
term infection that has a more pronounced effect on inflammation.
There is also some evidence to show that higher levels of
periodontal pathogens are associated with more aggressive forms
of periodontitis [48], [49]. Importantly, the positive associations
among those with periodontal disease were independent of H.
pylori and other established risk factors. If results are confirmed in
future studies, the combined status of periodontal disease indices
and their corresponding pathogens may be considered risk factors
for gastric precancerous lesions and gastric cancer. Since bacterial
profiles and oral health conditions are modifiable, identification of
bacterial risk factors of malignancy could have important
implications for cancer prevention.
In the present study, the positive associations between selected
pathogens or their cumulative burden score and gastric precan-
cerous lesions were similar across bacterial species among
participants with higher levels of periodontal disease indices.
The findings suggest a potential role of multiple periodontal
disease-related bacteria. An emerging concept in microbial
pathogenesis is the notion that the community functions as a
pathogen and contributes to disease development collectively,
rather than through the action of one specific member alone [50],
[51]. Future studies are needed to comprehensively investigate the
role of other oral pathogens or oral microbiomes related to
inflammation and periodontal disease in gastric cancer develop-
ment.
There were several strengths of the present study. First, clinical
indices of periodontal disease were measured objectively in a
consistent fashion for all participants. Second, the availability of
data on important risk factors of gastric cancer and potential
confounders enhanced the ability to control for potential
confounding and strengthened the validity of the study findings.
Third, the bacterial specificity of our findings lends further support
to the role of periodontal disease in the development of gastric
cancer. In our study, no apparent relationship was evident
between caries-related bacteria and gastric precancerous lesions.
This is consistent with our previous study, which found no
association between any clinical measure of caries (number of
decayed, missing, or filled teeth/tooth surfaces) and gastric
precancerous lesions20. In addition, the association between
selected periodontal disease bacteria and gastric precancerous
lesions were more evident for bacterial levels measured in pooled
plaque compared with levels measured in whole saliva. Levels of
microorganisms in subgingival plaque may be less diluted than in
saliva and therefore more sensitive to detection by real-time
qPCR.
Several potential limitations, however, should also be noted.
First, the study had a small sample size and therefore we would
have limited power to assess associations between oral pathogens
and gastric precancerous lesions if oral pathogens were treated as
categorical variables. We also investigated a number of compar-
isons in the study. Since p-values from the various models were not
independent and the work was hypothesis-oriented, we adjusted p-
values using the Benjamini–Hochberg false discovery rate (FDR)
method to account for multiple comparisons [52]. After adjust-
ment for FDR, the adjusted p-values for the interaction effects of
% CAL$3 mm with Pg and Tf remained marginally significant
(p = 0.08), while the significance of the other interactions did not
(FDR-adjusted p-value .0.15). Moreover, the inverse association
of T. forsythia with gastric precancerous lesions was no longer
significant (FDR-adjusted p-value = 0.25). Larger studies are
needed to confirm our findings and to further investigate the full
dose-response relationships. Second, the study is cross-sectional
and precludes any definitive statement regarding a causal
association. However, DNA levels of oral pathogens and
periodontal disease indices were measured objectively and were
blinded to case status. Although we cannot also exclude the
possibility of potential selection bias, it is not likely that cases with
severe periodontal disease preferentially volunteered to be
included in the study, since the hypotheses were not known to
participants and were unaware of their lesion status at the time of
recruitment for the oral health examination.
In conclusion, we found an overall non-significant positive
association between DNA levels of selected oral pathogens related
to periodontal disease, and the associations were stronger among
individuals with higher levels of periodontal disease indices. Our
findings highlight the role of periodontal infection in the
development of gastric cancer.
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